Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuichi Tamura

Showing results (121-130 of 155) with videos related to

Pageof 16
Sort By:
Journal of Cardiac Failure|September 3, 2024
Prevalence and Prognostic Implications of Changes in Tricuspid Regurgitation Severity in Acute Heart FailureTetsuya Kobayashi, Yuya Matsue, Yudai Fujimoto, et al.
Oncotarget|November 2, 2017
A genome-wide association analysis identifies <i>PDE1A</i>|<i>DNAJC10</i> locus on chromosome 2 associated with idiopathic pulmonary arterial hypertension in a Japanese populationMai Kimura, Yuichi Tamura, Christophe Guignabert, et al.
Journal of Gastroenterology|May 19, 2019
Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide surveyMakoto Naganuma, Shinya Sugimoto, Hideo Suzuki, et al.
Circulation|November 13, 2023
A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI TrialKazuya Hosokawa, Hiroko Watanabe, Yu Taniguchi, et al.
The Journal of Clinical Investigation|August 3, 2016
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertensionChristophe Guignabert, Carole Phan, Andrei Seferian, et al.
BMJ Open|August 24, 2023
Evaluation of the efficacy and safety of an integrated telerehabilitation platform for home-based cardiac REHABilitation in patients with heart failure (E-REHAB): protocol for a randomised controlled trialMisato Chimura, Shinji Koba, Yasushi Sakata, et al.
ERJ Open Research|December 17, 2025
Long-term outcomes of Qing-Dai-induced pulmonary arterial hypertensionSarasa Isobe, Ly Tu, Yoshihiro Dohi, et al.
Circulation|November 1, 2021
Electrocardiographic Manifestations of Immune Checkpoint Inhibitor MyocarditisJohn R Power, Joachim Alexandre, Arrush Choudhary, et al.
Journal of the American Heart Association|March 20, 2026
Prognostic Impact of Elevated Pulmonary Vascular Resistance in Group 2 Pulmonary Hypertension: Insights From a Japanese Multicenter RegistryTaijyu Satoh, Koichiro Sugimura, Yoshihiro Fukumoto, et al.
JACC. Asia|August 19, 2024
Outcomes of Chronic Thromboembolic Pulmonary Hypertension After Balloon Pulmonary Angioplasty and Pulmonary EndarterectomyKohei Masaki, Kazuya Hosokawa, Kouta Funakoshi, et al.
Pageof 16

Showing results (121-130 of 155) with videos related to

Sort By:
Pageof 16
Journal of Cardiac Failure|September 3, 2024
Prevalence and Prognostic Implications of Changes in Tricuspid Regurgitation Severity in Acute Heart FailureTetsuya Kobayashi, Yuya Matsue, Yudai Fujimoto, et al.
Oncotarget|November 2, 2017
A genome-wide association analysis identifies <i>PDE1A</i>|<i>DNAJC10</i> locus on chromosome 2 associated with idiopathic pulmonary arterial hypertension in a Japanese populationMai Kimura, Yuichi Tamura, Christophe Guignabert, et al.
Journal of Gastroenterology|May 19, 2019
Adverse events in patients with ulcerative colitis treated with indigo naturalis: a Japanese nationwide surveyMakoto Naganuma, Shinya Sugimoto, Hideo Suzuki, et al.
Circulation|November 13, 2023
A Multicenter, Single-Blind, Randomized, Warfarin-Controlled Trial of Edoxaban in Patients With Chronic Thromboembolic Pulmonary Hypertension: KABUKI TrialKazuya Hosokawa, Hiroko Watanabe, Yu Taniguchi, et al.
The Journal of Clinical Investigation|August 3, 2016
Dasatinib induces lung vascular toxicity and predisposes to pulmonary hypertensionChristophe Guignabert, Carole Phan, Andrei Seferian, et al.
BMJ Open|August 24, 2023
Evaluation of the efficacy and safety of an integrated telerehabilitation platform for home-based cardiac REHABilitation in patients with heart failure (E-REHAB): protocol for a randomised controlled trialMisato Chimura, Shinji Koba, Yasushi Sakata, et al.
ERJ Open Research|December 17, 2025
Long-term outcomes of Qing-Dai-induced pulmonary arterial hypertensionSarasa Isobe, Ly Tu, Yoshihiro Dohi, et al.
Circulation|November 1, 2021
Electrocardiographic Manifestations of Immune Checkpoint Inhibitor MyocarditisJohn R Power, Joachim Alexandre, Arrush Choudhary, et al.
Journal of the American Heart Association|March 20, 2026
Prognostic Impact of Elevated Pulmonary Vascular Resistance in Group 2 Pulmonary Hypertension: Insights From a Japanese Multicenter RegistryTaijyu Satoh, Koichiro Sugimura, Yoshihiro Fukumoto, et al.
JACC. Asia|August 19, 2024
Outcomes of Chronic Thromboembolic Pulmonary Hypertension After Balloon Pulmonary Angioplasty and Pulmonary EndarterectomyKohei Masaki, Kazuya Hosokawa, Kouta Funakoshi, et al.
Pageof 16